Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: A case report and review literature

Turk Psikiyatri Dergisi

Volumn 18, Issue 2, 2007, Pages

  Buhagiar, Kurt ^a   Cassar, Joseph ^a  

^a NONE

Author keywords

Depression augmentation; Fluvaxamine methylphenidate; Psychostimulants; Refractory depression

Indexed keywords

EID: 39349096911     PISSN: 13002163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. American Psychiatric Association (2004) Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. Washington DC: American Psychiatric Association.
2. Bader GM, Hawley JM, Short DD (1998) Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report. J Clin Psychopharmacol, 18: 255-256.
3. Biederman J (1998) Attention-deficit/hyperactivity disorder: a lifespan perspective. J Clin Psychiatry, 59 (Suppl 7): 4-16.
4. Chiuch CC, Moore KE (1975) Blockade by reserpine of methylphenidate-induced release of brain dopamine. J Pharmacol Exp Ther, 193: 559-563.
5. Craig Nelson J (1998) Treatment of antidepressant nonresponders: augmentation or switch? J Clin Psychiatry; 59 (Suppl 15): 35-41.
6. Fawcetr J, Kravitz HM, Zajecka JM et al. (1991) CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. J Clin Psychopharmacol 11: 127-132.
7. Goldman LS, Genel M, Bezman RJ et al. (1998) Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA, 279: 1100-1107.
8. Gwirtsman HE (1994) The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate Psychopharmacol Bull, 30: 157-164.
9. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry, 23: 56-62.
10. Hurd YL, Ungerstedt U (1989) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur J Pharmacol, 166: 251-260.
11. Lavretsky H, Kumar A (2001) Methylphenidate augmentation of citalopram in elderly depressed patients. Am J Geriatr Psychiatry, 9: 298-303.
12. Lavretsky H, Park S, Siddarth P et al. (2006) Methylphenidate-enhance antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial. Am J Geriatr Psychiatry; 14: 181-185.
13. Marin RS (1996) Apathy: concept, syndrome, neural mechanisms, and treatment. Sem Clin Neuropsychiatry, 1: 304-314.
14. Metz A, Shader RI (1991) Combination of fluoxetine with pemoline in the treatment of major depressive disorder. Int Clin Psychopharmacol, 6: 93-6.
15. Nierenberg AA, Gougherty D; Rosenbaum JF (1998) Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry, 59 (Suppl 15): 60-63.
16. Postolache TT, Rosenthal RN, Hellerstein DJ et al. (1999) Early augmentation of sertraline with methylphenidate. J Clin Psychiatry, 60: 123-124.
17. Satel SL, Nelson JC (1989) Stimulants in the treatment of depression: a critical review. J Clin Psychiatry, 50: 241-249.
18. Schatzberg AF, Cole JO (1991) Manual of clinical pharmacology. Washington DC: American Psychiatric Press, p. 247-259.
19. Steur EN (1993) Increase of Parkinson disability after fluoxetine medication. Neurol, 43: 211-213
20. Stimpson N, Agrawal N, Lewis G (2002) Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry, 181: 284-294.
21. Stoll A, Pillay SS, Diamond L, et al. (1996) Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J Clin Psychiatry, 57: 72-76.
22. Thase ME, Howland RH, Friedman ES (1998) Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry, 59 (Suppl 15): 5-12.
23. Thomas C, Lipsky JL (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc, 75: 711-721.
24. Wallace AT, Kofoed LL, West AN (1995) Double-blinti, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry, 152: 929-31.
25. Warneke L (1990) Psychostimulants in psychiatry. Can J Psychiatry, 35: 3-10.